International Stem Cell Corporation (ISCO)
OTCMKTS
· Delayed Price · Currency is USD
0.176
+0.036 (25.79%)
Mar 9, 2026, 3:59 PM EST
International Stem Cell Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 9.39 | 9.09 | 7.79 | 8.18 | 7.18 | 7.13 | Upgrade
|
| Revenue Growth (YoY) | 10.12% | 16.64% | -4.78% | 13.99% | 0.67% | -24.75% | Upgrade
|
| Cost of Revenue | 3.96 | 3.76 | 3.18 | 3.27 | 2.94 | 2.78 | Upgrade
|
| Gross Profit | 5.43 | 5.32 | 4.61 | 4.91 | 4.24 | 4.35 | Upgrade
|
| Selling, General & Admin | 5.06 | 5.17 | 5.2 | 5.05 | 5.9 | 6.79 | Upgrade
|
| Research & Development | 0.28 | 0.22 | 0.07 | 0.04 | 0.01 | 0.31 | Upgrade
|
| Operating Expenses | 5.34 | 5.39 | 5.27 | 5.09 | 5.91 | 7.1 | Upgrade
|
| Operating Income | 0.1 | -0.07 | -0.66 | -0.18 | -1.67 | -2.75 | Upgrade
|
| Interest Expense | -0.16 | -0.15 | -0.14 | -0.14 | -0.13 | -0.11 | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | 0 | 0.01 | -0.01 | 0.01 | 0.21 | Upgrade
|
| EBT Excluding Unusual Items | -0.06 | -0.21 | -0.79 | -0.33 | -1.79 | -2.66 | Upgrade
|
| Asset Writedown | - | - | - | - | -0.25 | -0.07 | Upgrade
|
| Other Unusual Items | - | - | 0.66 | - | 1.14 | - | Upgrade
|
| Pretax Income | -0.06 | -0.21 | -0.13 | -0.33 | -0.9 | -2.72 | Upgrade
|
| Net Income | -0.06 | -0.21 | -0.13 | -0.33 | -0.9 | -2.72 | Upgrade
|
| Net Income to Common | -0.06 | -0.21 | -0.13 | -0.33 | -0.9 | -2.72 | Upgrade
|
| Shares Outstanding (Basic) | 8 | 8 | 8 | 8 | 8 | 8 | Upgrade
|
| Shares Outstanding (Diluted) | 8 | 8 | 8 | 8 | 8 | 8 | Upgrade
|
| Shares Change (YoY) | - | - | - | 2.19% | 3.90% | 0.35% | Upgrade
|
| EPS (Basic) | -0.01 | -0.03 | -0.02 | -0.04 | -0.11 | -0.36 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.03 | -0.02 | -0.04 | -0.11 | -0.36 | Upgrade
|
| Free Cash Flow | -0.14 | -0.15 | 0.85 | 0.33 | -1.32 | -0.37 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.02 | 0.11 | 0.04 | -0.17 | -0.05 | Upgrade
|
| Gross Margin | 57.86% | 58.57% | 59.16% | 60.04% | 59.10% | 60.98% | Upgrade
|
| Operating Margin | 1.03% | -0.75% | -8.51% | -2.24% | -23.29% | -38.62% | Upgrade
|
| Profit Margin | -0.63% | -2.30% | -1.68% | -4.05% | -12.53% | -38.21% | Upgrade
|
| Free Cash Flow Margin | -1.48% | -1.68% | 10.90% | 4.05% | -18.39% | -5.18% | Upgrade
|
| EBITDA | 0.32 | 0.14 | -0.47 | 0.04 | -1.41 | -2.5 | Upgrade
|
| EBITDA Margin | 3.36% | 1.52% | -6.02% | 0.43% | -19.63% | -35.07% | Upgrade
|
| D&A For EBITDA | 0.22 | 0.21 | 0.19 | 0.22 | 0.26 | 0.25 | Upgrade
|
| EBIT | 0.1 | -0.07 | -0.66 | -0.18 | -1.67 | -2.75 | Upgrade
|
| EBIT Margin | 1.03% | -0.75% | -8.51% | -2.24% | -23.29% | -38.62% | Upgrade
|
| Advertising Expenses | - | 0.18 | 0.2 | 0.22 | 0.17 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.